Skip to main content
Refractory metastatic CRC: Raltitrexed plus S-1 betters regorafenib in prolonging survival
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Refractory metastatic CRC: Raltitrexed plus S-1 betters regorafenib in prolonging survival
User login
Username
Password
Reset your password
Type
Lead
score